THC Therapeutics, Inc. engages in developing a sanitizing herb dryer, the dHydronator, which has been specifically designed for the drying and sanitizing of freshly harvested cannabis, and other herbs, flowers, and tea leaves. The company is headquartered in Las Vegas, Nevada and currently employs 1 full-time employees. The company went IPO on 2007-12-07. The firm is focused on developing a sanitizing herb dryer, the dHydronator, with multiple design, function, and usage patents. The dHydronator product is specifically designed for the drying and sanitizing (i.e., reducing the bacterial count by using ultraviolet light) of freshly harvested cannabis, and other herbs, flowers, and tea leaves. The dHydronator can reduce the moisture content of cannabis to 10-15% in only 10-14 hours. The company can also reduce the bacterial count of cannabis during the drying process. The firm also operates a portfolio of companies in genetics, cultivation, extraction, and distribution as well as specialty real estate and nutrients for commercial and hobby cannabis growers. These companies consist of Jefferson Soul, Kalix, NPK Industries, Harvest Food for Life, Shasta Properties Management, and Blue Sky Investments.
Follow-Up Questions
¿Qué tal es el rendimiento del precio de la acción THCT?
El precio actual de THCT es de $0.0001, ha decreased un 0% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de THC Therapeutics Inc?
THC Therapeutics Inc pertenece a la industria Health Care y el sector es Health Care
¿Cuál es la capitalización bursátil de THC Therapeutics Inc?
La capitalización bursátil actual de THC Therapeutics Inc es $4.0K